首頁 > 市場調查報告書 > 醫療設備

體外診斷

快速檢測市場規模、佔有率和成長分析：按產品類型、應用、檢體類型、技術、最終用戶、分銷管道和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2054225

快速檢測市場規模、佔有率和成長分析：按產品類型、應用、檢體類型、技術、最終用戶、分銷管道和地區分類－2026-2033年產業預測

Rapid Tests Market Size, Share, and Growth Analysis, By Product Type, By Application, By Sample Type, By Technology, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2026年05月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球快速偵測市場價值為 382 億美元，預計到 2025 年將成長至 410.3 億美元，到 2033 年將成長至 726.3 億美元，在預測期（2026-2033 年）內複合年成長率為 7.4%。

全球快速檢測市場專注於照護現場診斷，提供快速、通常為定性的結果，從而支持及時的臨床決策和公共衛生監測。最初，受新冠疫情的推動，對抗原和抗體檢測的需求凸顯了檢查室處理能力的不足，並促進了側向層析技術的創新。隨後，隨著投資的增加、監管政策的調整以及報銷範圍的擴大，市場不斷發展，其應用範圍也從感染疾病擴展到妊娠檢測、藥物篩檢和慢性病監測等領域。檢測靈敏度的提高和分散式檢查基礎設施的進步顯著影響了市場結構，增強了醫療專業人員和消費者的信心，並加速了檢測技術的普及。人工智慧的整合提高了診斷準確性，並被應用於訊號檢測、影像分析和檢測設計等領域。總而言之，這些進步正在為這個快速成長的行業創造新的商機。

全球快速檢測市場的成長要素

全球快速檢測市場的主要促進因素之一是對快速、準確的診斷解決方案日益成長的需求，尤其是在感染疾病和慢性病領域。即時檢測（POCT）越來越受歡迎，因為它可以即時獲得結果，從而加快臨床決策並改善患者管理。此外，醫療保健意識的提高和醫療基礎設施的不斷完善，尤其是在新興經濟體，正在推動快速檢測技術的應用。這些因素，加上檢測技術研發的不斷進步，例如靈敏度和特異性的提高，進一步推動了市場成長和創新。

全球快速檢測市場的限制因素

影響全球快速檢測市場的主要限制因素之一是檢測產品的監管和標準化。嚴格的政府法規以及全面的檢驗和核准流程要求可能會延緩創新型快速檢測產品的上市。此外，不同地區監管標準的差異也使製造商面臨許多挑戰，導致成本增加和產品上市時間延長。這些監管條件可能會阻礙新公司進入市場，並限制現有公司的擴張，最終可能阻礙全球快速檢測解決方案的整體成長和普及。

全球快速檢測市場趨勢

全球快速檢測市場正經歷著向分散式檢查的顯著轉變，這主要得益於社區診所、藥房、職場和家庭等非傳統場所對快速檢測需求的持續成長。這一趨勢有助於早期發現和有效管理各種健康狀況。製造商正在改進產品設計，優先考慮易用性、減少培訓需求和安全處置，而服務供應商則在引入創新的交付模式，以提高可及性和便利性。對快速臨床決策支援的關注正在促進檢測開發商、即時檢測 (PoC) 網路和零售醫療管道之間的策略夥伴關係，最終將檢測整合到常規護理流程中，並擴大市場覆蓋範圍。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Abbott Laboratories
Roche
QuidelOrtho
BD
Siemens Healthineers
bioMerieux
Danaher Corporation
Thermo Fisher Scientific
OraSure Technologies
ACON Laboratories
SD Biosensor
Access Bio
Bionote
Sekisui Medical
Trinity Biotech
Nova Biomedical
Hangzhou AllTest Biotech
Wondfo Biotech
QIAGEN
Sysmex

結論與建議

簡介目錄

Product Code: SQMIG35A3541

Global Rapid Tests Market size was valued at USD 38.2 Billion in 2024 and is poised to grow from USD 41.03 Billion in 2025 to USD 72.63 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global rapid tests market focuses on point-of-care diagnostics that yield quick, often qualitative results, facilitating timely clinical decisions and public health surveillance. Initially propelled by the COVID-19 pandemic, the demand for antigen and antibody tests highlighted vulnerabilities in laboratory capacities and sparked innovations in lateral flow technology. This market has since evolved through increased investments, regulatory changes, and enhanced reimbursement, expanding its reach beyond infectious diseases to include pregnancy, drug screening, and chronic care monitoring. Advances in assay sensitivity and decentralized testing infrastructure significantly impact the landscape, fostering clinician and consumer trust and driving adoption. The integration of AI enhances diagnostic accuracy, with applications in signal detection, image interpretation, and assay design. Overall, these developments present new revenue opportunities in a rapidly growing industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Tests market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Tests Market Segments Analysis

Global rapid tests market is segmented by product type, application, sample type, technology, end user, distribution channel and region. Based on product type, the market is segmented into Lateral Flow Assays, Rapid Antigen Tests, Rapid Antibody Tests, Molecular Rapid Tests, Dipstick Tests and Others. Based on application, the market is segmented into Infectious Disease Testing, Pregnancy & Fertility Testing, Cardiac Marker Testing, Glucose Monitoring, Drug Abuse Testing and Others. Based on sample type, the market is segmented into Blood, Urine, Saliva, Nasal & Throat Swabs and Others. Based on technology, the market is segmented into Immunochromatographic Assays, Molecular Diagnostics, Biosensor-Based Testing and Microfluidic Testing. Based on end user, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Homecare Settings, Ambulatory Care Centers and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Direct Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rapid Tests Market

One of the key market drivers for the Global Rapid Tests Market is the increasing demand for timely and accurate diagnostic solutions, particularly in the context of infectious diseases and chronic health conditions. The growing preference for point-of-care testing allows for immediate results, facilitating quicker clinical decisions and improving patient management. Moreover, the rise in healthcare awareness and the expansion of healthcare infrastructure, especially in emerging economies, are propelling the adoption of rapid testing technologies. These factors, combined with the ongoing advancements in test development, such as enhanced sensitivity and specificity, further drive market growth and innovation.

Restraints in the Global Rapid Tests Market

One major restraint affecting the global rapid tests market is the regulation and standardization of testing products. Stringent government regulations and the requirement for comprehensive validation and approval processes can slow down the introduction of innovative rapid tests. Additionally, varying regulatory standards across different regions can create complexities for manufacturers, leading to increased costs and extended timelines for market entry. This regulatory landscape may deter new companies from entering the market or limit the expansion of existing firms, ultimately hindering the overall growth and accessibility of rapid testing solutions worldwide.

Market Trends of the Global Rapid Tests Market

The Global Rapid Tests market is witnessing a significant shift towards decentralized testing, as the demand for rapid tests in nontraditional settings like community clinics, pharmacies, workplaces, and homes continues to surge. This trend is facilitating earlier detection and effective management of various health conditions. Manufacturers are evolving their product designs to prioritize ease of use, minimal training, and safe disposal, while service providers implement innovative delivery models that enhance accessibility and convenience. The emphasis on rapid clinical decision support is fostering strategic partnerships among test developers, point-of-care networks, and retail health channels, ultimately integrating testing into routine care pathways and expanding market reach.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
Value Chain Analysis
Case Studies
Technology Assessment
Customer & Buying Criteria Analysis
Pipeline Analysis
Disease Epidemiology

Global Rapid Tests Market Size by Product Type & CAGR (2026-2033)

Market Overview
Lateral Flow Assays
Rapid Antigen Tests
Rapid Antibody Tests
Molecular Rapid Tests
Dipstick Tests
Others

Global Rapid Tests Market Size by Application & CAGR (2026-2033)

Market Overview
Infectious Disease Testing
Pregnancy & Fertility Testing
Cardiac Marker Testing
Glucose Monitoring
Drug Abuse Testing
Others

Global Rapid Tests Market Size by Sample Type & CAGR (2026-2033)

Market Overview
Blood
Urine
Saliva
Nasal & Throat Swabs
Others

Global Rapid Tests Market Size by Technology & CAGR (2026-2033)

Market Overview
Immunochromatographic Assays
Molecular Diagnostics
Biosensor-Based Testing
Microfluidic Testing

Global Rapid Tests Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Diagnostic Laboratories
Homecare Settings
Ambulatory Care Centers
Others

Global Rapid Tests Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Direct Sales

Global Rapid Tests Market Size & CAGR (2026-2033)

North America (Product Type, Application, Sample Type, Technology, End User, Distribution Channel)
- US
- Canada
Europe (Product Type, Application, Sample Type, Technology, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, Sample Type, Technology, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, Sample Type, Technology, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, Sample Type, Technology, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SD Biosensor
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Access Bio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bionote
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nova Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hangzhou AllTest Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wondfo Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments